Related Experiment Video

Updated: Apr 16, 2026

Author Spotlight: Establishing a Practical and Cost-Effective Protocol for Corneal Sensitivity Testing in Clinical Settings

Author Spotlight: Establishing a Practical and Cost-Effective Protocol for Corneal Sensitivity Testing in Clinical Settings

Published on: August 2, 2024

Highlights in NSCLC from the 2014 ASCO meeting

Mark A Socinski¹

¹University of Pittsburgh, Pittsburgh, Pennsylvani.

Clinical Advances in Hematology & Oncology : H&O

|March 14, 2015

Abstract

No abstract available in PubMed .

Related Concept Videos

Articles linked to this work by shared authors, journal, and citation graph.

AdvanTIG-302: Phase 3 Study of Ociperlimab (Anti-TIGIT) + Tislelizumab (Anti-PD-1) Versus Pembrolizumab in Untreated, Locally Advanced, Unresectable, or Metastatic Non-Small Cell Lung Cancer With PD-L1 ≥50.

Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer·2026

Tiragolumab Plus Atezolizumab and Chemotherapy for Advanced Nonsquamous Non-Small Cell Lung Cancer: The Phase 3 SKYSCRAPER-06 Randomized Clinical Trial.

JAMA oncology·2026

Gotistobart or docetaxel in metastatic squamous non-small cell lung cancer: stage 1 of the randomized phase 3 PRESERVE-003 trial.

Nature medicine·2026

Non-small cell lung cancer molecular subtypes and vulnerability to immunotherapy treatment combinations.

Nature communications·2025

Phase 2 Study of Zilovertamab Vedotin in Participants with Metastatic Solid Tumors.

Cancer research communications·2025

Digital Versus Manual PD-L1 Scoring in Advanced NSCLC From the IMpower110 and IMpower150 Trials.

Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer·2025

See all related articles